EMVision Medical Devices (ASX: EMV) has released what it claims is “promising” first stroke patient images from a pilot clinical trial that aims to improve the understanding of stroke on electromagnetic scattering effects in the brain.
According to the portable medical imaging technology developer, EMVision brain scans have demonstrated a strong correlation with ground truth scans of patients using the “gold standard imaging methods” of MRI and CT.
This correlation includes the detection and localisation of abnormal brain tissue, the company reported.
